Platelet Rich Plasma for Treatment of Nonhealing Diabetic Foot Ulcers: A Case Report Masoud Mehrannia, MD, Mitra Vaezi, MD, Fardin Yousefshahi, MD, Nahid.

Slides:

Advertisements

Similar presentations

Diabetes Management in Long-Term Care: An Exploratory Study of the Current Practices and Processes to Managing Frail Elderly Persons with Type 2 Diabetes.

Advertisements

Positioning Considerations in Robotic Surgery Christina Hortman, BSN, RN, Simon Chung, MD, MPH, MBA, FACS AORN Journal Volume 102, Issue 4, Pages

La néphropathie chronique en présence de diabète Canadian Journal of Diabetes Volume 37, Pages S504-S512 (October 2013) DOI: /j.jcjd

Management of severe anemia secondary to menorrhagia in a Jehovah's Witness: a case report and treatment algorithm Griselda Gutierrez, MD, FACOG, Joy.

Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP) Jeff Donovan, MD, PhD, FRCPC JAAD.

The Epidemic of the 20th Century: Coronary Heart Disease

Ivana Roth-Albin, CCRA, MSc, BSc, Safiah H. C

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

Clinical evaluation of recombinant human platelet – derived growth factor for the treatment of lower extremity diabetic ulcers David L. Steed, MD, the.

Myocardial Necrosis in a Patient with Mixed Connective Tissue Disease

Navin K. Jain, MD, Thiam H. Lie, MD, FCCP CHEST

Bleeding Toes in Diabetic Neuropathy

Stephen R. Broderick, MD, MPHS

Diabetes and Pregnancy

Diabetic Retinopathy: An Update on Treatment

An Unusual Cause of Leg Ulcerations

Electronic Health Record Use, Intensity of Hospital Care, and Patient Outcomes Saul Blecker, MD, MHS, Keith Goldfeld, DrPH, Naeun Park, MS, Daniel Shine,

Bleeding Toes in Diabetic Neuropathy

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

One Appendix, Two Different Pains

Efficacy of topical application of eosin for ulcerated hemangiomas

María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD

Reducing the Risk of Developing Diabetes

Schizophrenia for Primary Care Providers: How to Contribute to the Care of a Vulnerable Patient Population Mark Viron, MD, Travis Baggett, MD, MPH, Michele.

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD

The Epidemic of the 20th Century: Coronary Heart Disease

A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis Lorinda Chung, MD, David Fiorentino,

Misconceptions and Facts About Hypertrophic Cardiomyopathy

Chronic Kidney Disease in Diabetes

Volume 1, Issue 5, Pages (September 2015)

Philipp Schuetz, MD, Maura Kennedy, MD, Jason M

Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP) Jeff Donovan, MD, PhD, FRCPC JAAD.

The Reply The American Journal of Medicine

Treatment of hepatitis C

An Enlarging Ulcer The American Journal of Medicine

Family Caregiver Perspectives on Symptoms and Treatments for Patients Dying From Complications of Cystic Fibrosis Elisabeth P. Dellon, MD, MPH, Mitchell.

Louis L. Nguyen, MD, MBA, MPH Journal of Vascular Surgery

Lip edema Journal of the American Academy of Dermatology

Infected aneurysm of the thoracic aorta

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

Ventricular assist device abdominal driveline infection: Treatment with platelet-rich plasma Federica Jiritano, MD, Giuseppe Filiberto Serraino, MD,

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Support Your Specialty

Stephen R. Broderick, MD, MPHS

Study Designs in Patient-Oriented Research

Volume 17, Issue 2, Pages (February 1950)

Recreational Injuries in Washington State National Parks

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D

Divalproex sodium: A potential therapy for scleroderma digital ulcers

A Surfeit of Possibilities: Nonhealing Ulcers

A Post-cure Complication

Spherical Pneumonia CHEST

Plasma Lactescence in Acute Pancreatitis

Differences in Blood Transfusion Trends Between US and UK Centers

Pheochromocytoma Presenting as Fever of Unknown Origin

Bilateral sole hyperkeratosis and nonhealing foot mass

Screening and Treatment of Vitamin D Deficiency on Hospital Admission: Is There a Benefit for Medical Inpatients? Lena Grädel, MD, Meret Merker, BMSc,

Trends in Prolonged Hospitalizations in the United States from 2001 to 2012: A Longitudinal Cohort Study Lauren Doctoroff, MD, Douglas J. Hsu, MD, Kenneth.

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

In pregnancy, aortic tissue is the issue

Tofacitinib therapy for children with severe alopecia areata

Volume 4, Issue 1, Pages 2-3 (February 2006)

New Approaches to the Treatment of Pemphigus

‘Krokodil’—A Designer Drug from Across the Atlantic, with Serious Consequences Dany V. Thekkemuriyi, MD, Santhosh Gheevarghese John, MD, Unnikrishnan.

Suzanne C. Byrne, MD, Brendan Barrett, MD, Rick Bhatia, MD

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Heparin-induced Thrombocytopenia in Patients Receiving Plasma Exchange

How do we follow up our patients

Phosphate Balance in Continuous Venovenous Hemofiltration

Presentation transcript:

Platelet Rich Plasma for Treatment of Nonhealing Diabetic Foot Ulcers: A Case Report Masoud Mehrannia, MD, Mitra Vaezi, MD, Fardin Yousefshahi, MD, Nahid Rouhipour, MD, MPH Canadian Journal of Diabetes Volume 38, Issue 1, Pages 5-8 (February 2014) DOI: 10.1016/j.jcjd.2013.08.271 Copyright © 2014 Canadian Diabetes Association Terms and Conditions

Figure 1 Photograph of the patient's soles (left and right) at the time of admission to hospital (before PRP treatment). Canadian Journal of Diabetes 2014 38, 5-8DOI: (10.1016/j.jcjd.2013.08.271) Copyright © 2014 Canadian Diabetes Association Terms and Conditions

Figure 2 Photograph of the patient's feet (right and left) (A) Ten days after PRP treatment (Bio-Act from bioJel Inc.). (B) Twenty days after PRP treatment (Bio-Act from bioJel Inc.); granulation tissue as well as some re-epithelialization is apparent. (C) Six weeks after PRP treatment (Bio-Act from bioJel Inc.). Canadian Journal of Diabetes 2014 38, 5-8DOI: (10.1016/j.jcjd.2013.08.271) Copyright © 2014 Canadian Diabetes Association Terms and Conditions

Figure 3 Photograph of the patient’s feet (right and left) at the end of the 8 months follow-up period. Canadian Journal of Diabetes 2014 38, 5-8DOI: (10.1016/j.jcjd.2013.08.271) Copyright © 2014 Canadian Diabetes Association Terms and Conditions